www.pdci.ca Open in urlscan Pro
45.60.73.130  Public Scan

Form analysis
1 forms found in the DOM

GET https://www.pdci.ca/

<form action="https://www.pdci.ca/" method="get">
  <input type="text" name="s" value="" class="global-radius" placeholder="Search">
</form>

Text Content

BESbswyBESbswy
Tel: (613) 742-8225
/
info@pdci.ca
 * 
 * 

 * 

 * Newsletter Sign-Up
 * Login to PDCI Services
 * Contact Us

Navigation
 * Home
 * About Us
   * What We Do
     * Develop Effective P&R Strategies
     * Establish Optimal Pricing
     * Demonstrate Value
     * Achieve Timely Market Access
   * Our Team
   * Careers
 * Services
   * Case Studies
 * News & Events
 * Resources
   * Provincial & CDR Deadlines
     * Common Drug Review (CDR) Submission Deadlines and CDEC Meeting Dates
   * PMPRB
     * PMPRB CPI Adjustment Factors Allowable Price Increases
     * PMPRB HDAP Meeting Dates & Submission Deadlines
   * Links
 * Consultation Responses
 * Blog
 * Publications

   
 * 
   
 * 







WE HELP PHARMA / BIOTECH FIRMS:



DEVELOP EFFECTIVE
P&R STRATEGIES

More Info

ESTABLISH OPTIMAL
PRICING

More Info

DEMONSTRATE
VALUE

More Info

ACHIEVE TIMELY
MARKET ACCESS

More Info




WHAT'S NEW






14

NOV

PMPRB PROVIDES THEMES FOR FIRST STEP OF GUIDELINES CONSULTATION; ANNOUNCES
APPOINTMENTS OF TWO NEW BOARD MEMBERS

Read More


13

NOV

PMPRB INVITES STAKEHOLDER FEEDBACK ON SCOPING PAPER ON THEMES FOR NEW GUIDELINES

Read More


02

OCT

PMPRB PUBLISHES FINAL DECISION ON AMENDED INTERIM GUIDANCE

Read More


08

SEP

PDCI STRENGTHENS LEADERSHIP TO ENHANCE REAL WORLD EVIDENCE (RWE) SERVICES AND
STRATEGIC CONSULTING CAPABILITIES

Read More


05

SEP

PCPA APPOINTS DOUGLAS CLARK AS ITS FIRST CEO

Read More


03

AUG

PCPA SEEKS STAKEHOLDER INPUT ON ITS PROPOSED PROCESS TO IMPLEMENT CADTH
TIME-LIMITED RECOMMENDATIONS

Read More


11

JUL

UPDATES ON PMPRB ACTIVITIES IN JUNE 2023 NEWSLETTER

Read More


11

JUL

CADTH ANNOUNCES CHANGES TO REIMBURSEMENT REVIEWS PROCESS & FEE SCHEDULE UPDATE

Read More


11

JUL

PMPRB LAUNCHES CONSULTATION ON ITS AMENDMENT TO THE INTERIM GUIDANCE RE: NEW
MEDICINES

Read More


02

MAY

PDCI’S WEBINAR SERIES: TIPS FOR HEALTH TECHNOLOGY ASSESSMENT (HTA) SUBMISSIONS:
PLAN YOUR TRIP, PACK YOUR BAGS AND LEAVE ON TIME

Read More


01

MAY

CONNECT WITH PDCI MARKET ACCESS AT THE CADTH SYMPOSIUM IN OTTAWA, MAY 16-18,
2023

Read More


23

MAR

FEDERAL GOVERNMENT ALLOCATES UP TO $1.4 BILLION TO IMPROVE ACCESS TO DRUGS FOR
RARE DISEASES

Read More


07

MAR

PDCI CONTINUES TO GROW ITS HEALTH ECONOMY CAPABILITIES WITH THE ADDITION OF ERIC
& NATHALIE

Read More


07

MAR

MÉLANIE BOURASSA FORCIER REFERENCES “DIALOGUE OF THE DEAF” BETWEEN PMPRB AND
INDUSTRY AMONG REASONS FOR HER RESIGNATION FROM PMPRB

Read More


01

MAR

INESSS FEE SCHEDULE UPDATE; UPCOMING CADTH CONSULTATION AND APPLICATION PROCESS
UPDATES

Read More


24

FEB

DOUG CLARK RESIGNS FROM PMPRB

Read More


24

FEB

PMPRB BOARD MEMBER RESIGNS

Read More


13

FEB

PMPRB NEW CHAIRPERSON

Read More


13

FEB

 PCPA RECRUITING THEIR FIRST CEO

Read More


20

DEC

UPDATES TO THE QUEBEC GUIDELINES FOR DRUG SUBMISSION AND EVALUATION

Read More


19

DEC

PMPRB INTERIM CHAIRPERSON CONFIRMS RESIGNATION

Read More


05

DEC

PMPRB’S 2021 ANNUAL REPORT SHOWS WORRYING DECLINE IN NUMBER OF NEW MEDICINES
LAUNCHED IN CANADA; HDAP MEETING TENTATIVELY SCHEDULED FOR SPRING 2023

Read More


05

DEC

PDCI WELL WISHES FOR MANAGING DIRECTOR KAITLYN PROULX

Read More


05

DEC

CADTH PHARMACEUTICAL REVIEWS UPDATE INCLUDES LAUNCH OF RWE GUIDANCE CONSULTATION

Read More


22

NOV

PDCI LAUNCHES SHARING PAGE FOR PMRPB CONSULTATION ON DRAFT GUIDELINES- FALL 2022

Read More


22

NOV

FIRESIDE CHAT: TRENDS TO WATCH IN 2023
PDCI’S LUNCH TIME EDUCATIONAL WEBINAR SERIES

Read More


22

NOV

CADTH PHARMACEUTICAL REVIEWS UPDATE INCLUDES LAUNCH OF RWE GUIDANCE CONSULTATION

Read More


22

NOV

PDCI WELL WISHES FOR MANAGING DIRECTOR KAITLYN PROULX

Read More


13

OCT

PDCI’S EARLY INSIGHTS ON PMPRB DRAFT GUIDELINES

Read More


06

OCT

PMPRB RELEASES DRAFT GUIDELINES AND LAUNCHES 60-DAY CONSULTATION 

Read More


19

AUG

PMPRB IMPLEMENTS ITS INTERIM GUIDELINES WITH CLARIFICATIONS

Read More


20

JUL

PDCI LAUNCHES SHARING PAGE FOR PMPRB CONSULTATION SUBMISSIONS

Read More


30

JUN

PMPRB UPDATES: PROPOSED INTERIM GUIDELINES PUBLISHED

Read More


28

JUN

PDCI WELCOMES FRANÇOIS-XAVIER HOUDE TO THE TEAM
 

Read More


20

JUN

PRESS RELEASE: PDCI’S BIOPHARMACEUTICAL ECOSYSTEM INDEX: WHERE DOES CANADA RANK
ON ITS ATTRACTIVENESS FOR NEW MEDICINE LAUNCH

Read More


20

MAY

PDCI’S BIOPHARMACEUTICAL ECOSYSTEM INDEX
PART OF A LUNCH TIME EDUCATIONAL SERIES
 

Read More


05

MAY

CADTH UPDATE: ADVICE ON REAL-WORLD EVIDENCE (RWE) BY SCIENTIFIC ADVICE PROGRAM

Read More


25

APR

THE PMPRB TO CONSULT ON A DIFFERENT SET OF GUIDELINES

Read More


11

APR

CADTH: NEW CLINICAL EVIDENCE TEMPLATE REQUIREMENT FOR OCTOBER 2022 SUBMISSIONS

Read More


04

APR

PMPRB 2020 ANNUAL REPORT SHOWS ALMOST 30% DECREASE IN NEW PATENTED MEDICINES
REPORTED SINCE 2018

Read More


25

MAR

SUPREME COURT DISMISSES ATTORNEY GENERAL’S APPLICATION FOR LEAVE TO APPEAL FCA
DECISION IN PMPRB ALEXION SOLIRIS MATTER

Read More


23

FEB

NEW PDCI MARKET ACCESS INSIGHTS (VOLUME 2, ISSUE 2)

Read More


22

FEB

QUEBEC COURT STRIKES 2 OF 3 PMPRB CHANGES

Read More


14

FEB

REMINDER: FORM 3 FILING IS DUE TO THE PMPRB ON MARCH 1, 2022

Read More


31

JAN

UPDATES TO THE ONTARIO GUIDELINES FOR DRUG SUBMISSION AND EVALUATION

Read More


14

JAN

REGISTER NOW FOR PDCI’S WEBINAR: IMPACT AND IMPLICATIONS OF THE DELAYED
REGULATIONS AND PMPRB GUIDELINES

Read More


31

DEC

PDCI YEAR IN REVIEW

Read More


28

DEC

FURTHER DELAY TO THE PMPRB GUIDELINES AND AMENDED REGULATIONS

Read More


17

DEC

PDCI’S 2021 CENSUS OF INSURERS

Read More


17

DEC

NEW PDCI MARKET ACCESS INSIGHTS VOLUME 2, ISSUE 1

Read More


17

DEC

PMPRB PROPOSED AMENDMENTS TO THE JULY 1, 2021 GUIDELINES

Read More


17

DEC

CONSULTATION NOTICE: PROPOSED FRAMEWORK FOR A POTENTIAL PAN-CANADIAN FORMULARY

Read More


17

DEC

CADTH PHARMACEUTICAL REVIEWS UPDATE- ISSUE 27

Read More


07

DEC

WHITEPAPER: UNCOVERING THE HIDDEN COSTS OF TAKE-HOME CANCER DRUGS

Read More


13

SEP

WELCOME TO THE PDCI TEAM

Read More


10

AUG

JOHN ANACLETO JOINS PDCI AS DIRECTOR OF PRIVATE PAYER STRATEGIES & DATA INSIGHTS

Read More


03

AUG

PMPRB: FEDERAL COURT OF APPEAL QUASHES PMPRB ALEXION / SOLIRIS DECISION

Read More


26

JUL

DEADLINE EXTENDED: PMPRB NOTICE AND COMMENT

Read More


29

JUN

WELCOME JESSICA BIRRELL AND RACHEL ARCAND TO THE PDCI TEAM!

Read More


29

JUN

PATENTED MEDICINES REGULATIONS/PMPRB GUIDELINES FURTHER DELAYED UNTIL JANUARY 1,
2022

Read More


14

JUN

SAVE THE DATE! PMPRB HAS RELEASED UPCOMING WEBINAR ON JUNE 15TH

Read More


20

MAY

PDCI AT ISPOR: POSTER PRESENTATION ON ONCOLOGY COMPANION DIAGNOSTICS

Read More


11

MAY

PDCI MARKET ACCESS RELEASES NEW ISSUE OF INSIGHTS MAGAZINE PERSPECTIVES ON PLAN
SPONSORS AND NEW COVERAGE INSIGHTS

Read More


06

MAY

PMPRB ANNOUNCES THE GUIDELINE MONITORING AND EVALUATION PLAN (GMEP) CONSULTATION

Read More


19

APR

BREAKING NEWS: 2 REPORTING PERIODS FOR PMPRB MLP COMPLIANCE FOR GRANDFATHERED
AND GAP MEDICINES

Read More


14

APR

NACI PROCESS FOR INCORPORATING ECONOMIC EVIDENCE INTO FEDERAL VACCINE
RECOMMENDATIONS CONSULTATION

Read More


29

MAR

CADTH RELEASES PHARMACEUTICALS REVIEWS UPDATE – ISSUE 22

Read More


29

MAR

PATENTED MEDICINE PRICES REVIEW BOARD (PMPRB) 2019 ANNUAL REPORT PUBLISHED

Read More


24

MAR

REMINDER: PDCI SHARING SITES FOR POLICY SUBMISSIONS OPEN FOR CONTRIBUTION!

Read More


18

MAR

PMPRB FEBRUARY 15TH CONSULTATION – DECISION MADE FOR GAP MEDICINES AND TIMELINES
FOR COMPLIANCE

Read More


12

MAR

PDCI LAUNCHES TWO NEW SHARING SITES FOR POLICY SUBMISSIONS: 1. FEDERAL ISED
BIOMANUFACTURING CONSULTATION 2. HEALTH CANADA NATIONAL DRUGS FOR RARE DISEASES
CONSULTATION

Read More


26

FEB

WELCOME CHRIS BOODOO AND HUSSEIN EL-KHECHEN TO THE PDCI TEAM!

Read More


19

FEB

PDCI LAUNCHES SHARING PAGE FOR SUBMISSIONS TO THE PMPRB PROPOSED AMENDMENTS TO
THE NEW GUIDELINES

Read More


15

JAN

PMPRB PROPOSES AMENDMENTS TO NEW GUIDELINES: REQUESTS CONSULTATION FROM
STAKEHOLDERS

Read More


15

JAN

RELEASED: PMPRB11 POTENTIAL SOURCES FOR FOREIGN PRICES

Read More


08

JAN

WELCOME PIRAVEENA SABESAN TO PDCI MARKET ACCESS

Read More


06

JAN

PMPRB PUBLISHES NEW CPI FACTORS FOR 2021 PRICE INCREASES

Read More


29

DEC

PATENTED MEDICINES REGULATIONS/PMPRB GUIDELINES DELAYED UNTIL JULY 1, 2021

Read More


08

DEC

PMPRB WEBINAR ON ONLINE FILING TOOL (DECEMBER 7, 2020) – ATTACHMENT INCLUDED

Read More


07

DEC

PDCI MARKET ACCESS JOINS MCKESSON CANADA

Read More


03

DEC

INESSS ANNOUNCES THE ESTABLISHMENT OF A WAITING LIST FOR SCIENTIFIC EVALUATIONS

Read More


01

DEC

SAVE THE DATES! PMPRB HAS RELEASED UPCOMING WEBINAR DATES ON THE NEW GUIDELINES

Read More


25

NOV

PDCI’S PMPRB FOLLOW-UP WEBINAR POSTPONED

Read More


20

NOV

PDCI’S NEW ASSOCIATE DIRECTOR, PRICING & DATA ANALYTICS AND MANAGER, PRICING
DATA

Read More


16

NOV

WELCOME LAURA ROULSTON TO THE PDCI TEAM!

Read More


04

NOV

PMPRB PUBLIC WEBINAR DELAYED TO NOVEMBER 20, 2020

Read More


31

OCT

HOUSE OF COMMONS STANDING COMMITTEE ON HEALTH TO UNDERTAKE STUDY ON PMPRB
GUIDELINES

Read More


30

OCT

PMPRB IS HOSTING A PUBLIC WEBINAR ON NOVEMBER 10

Read More


28

OCT

REMINDER: PDCI IS HOSTING A WEBINAR ON THE PMPRB FINAL GUIDELINES

Read More


24

OCT

FINAL PMPRB GUIDELINES: A HIGH LEVEL SUMMARY

Read More


22

OCT

PMPRB FINAL GUIDELINES TO BE RELEASED FRIDAY, OCTOBER 23RD, 2020. PDCI WEBINAR
NOW SCHEDULED FOR THURSDAY, OCTOBER 29TH, 2020.

Read More


16

OCT

PMPRB FINAL GUIDELINES DELAYED, PDCI WEBINAR POSTPONED

Read More


14

OCT

PDCI WEBINAR: OVERVIEW OF THE FINAL PMPRB GUIDELINES

Read More


08

OCT

CADTH PHARMACEUTICAL REVIEWS UPDATE — ISSUE 17

Read More


01

OCT

SAVE THE DATE: PDCI HOSTING WEBINAR ON PMPRB FINAL GUIDELINES

Read More


30

SEP

PDCI MARKET ACCESS, CONNEX HEALTH CONSULTING AND H3 CONSULTING ARE PLEASED TO
RELEASE THE 2020 PRIVATE PAYER PLA REPORT!

Read More


30

SEP

PDCI PLA STUDY REPORT – PDCI MARKET ACCESS INC., CONNEX HEALTH CONSULTING, H3
CONSULTING

Read More


25

SEP

WELCOME MEVIN MATHEW, NICOLAS IRAGORRI AND SHABNA MOHIDEEN TO THE PDCI TEAM!

Read More


10

SEP

VOLUME 1 ISSUE 1 RELEASE OF PDCI MARKET ACCESS INSIGHTS JOURNAL

Read More


09

SEP

NEIL PALMER IS GUEST EDITOR, CELL & GENE THERAPY INSIGHTS SPOTLIGHT ON MARKET
ACCESS

Read More


09

SEP

CELL & GENE THERAPY INSIGHTS

Read More


19

AUG

PDCI’S 2020 CENSUS OF INSURERS NOW AVAILABLE!

Read More


04

AUG

PDCI LAUNCHES SHARING PAGE FOR SUBMISSIONS TO THE PMPRB DRAFT GUIDELINES
CONSULTATION (SUMMER 2020)

Read More


15

JUL

REMINDER: PDCI IS HOSTING A WEBINAR ON THE PMPRB GUIDELINES

Read More


13

JUL

A WEEK FULL OF NEWS AND HAPPENINGS AT PMPRB

Read More


07

JUL

NEW PDCI INFOGRAPHIC: BEST PRACTICES FOR CADTH REQUEST FOR RECONSIDERATION

Read More


02

JUL

REQUEST FOR RECONSIDERATION

Read More


30

JUN

PMPRB: FEDERAL COURT QUASHES REPORTING OF THIRD-PARTY DISCOUNTS & REBATES,
UPHOLDS OTHER PROVISIONS OF THE AMENDED PATENTED MEDICINES REGULATIONS

Read More


30

JUN

CADTH RELEASES PHARMACEUTICAL REVIEWS UPDATE – ISSUE 16

Read More


20

JUN

NEW DRAFT PMPRB GUIDELINES: A HIGH LEVEL SUMMARY

Read More


19

JUN

NOW RELEASED: PMPRB NEW DRAFT GUIDELINES

Read More


10

JUN

AMENDMENT TO THE PATENTED MEDICINES REGULATIONS PUBLISHED IN CANADA GAZETTE II

Read More


01

JUN

PMPRB GUIDELINES AND REGULATIONS UPDATE

Read More


29

MAY

DELAY OF IMPLEMENTATION OF PMPRB AMENDED REGULATIONS TO JANUARY 1, 2021

Read More


05

MAY

TARGETPHARMA – CADTH PHARMACEUTICAL REVIEW UPDATE 15

Read More


16

APR

PDCI LAUNCHES 2020 PRIVATE PAYER PLA STUDY

Read More


14

APR

IMPACT OF COVID-19-RELATED LAYOFFS ON PATIENTS’ ACCESS TO GROUP INSURANCE

Read More


06

APR

PDCI MARKET ACCESS INC. WELCOMES MARK FLEMING AS A STRATEGIC ADVISOR

Read More


31

MAR

PDCI ACQUIRES EXCLUSIVE LICENSE FOR TELUS HEALTH’S MARKET ACCESS TOOLKIT
INCLUDING INSIGHTS MAGAZINE AND CENSUS OF INSURERS

Read More


26

MAR

GOVERNMENT AUTHORIZES TEMPORARY COMPULSORY LISCENSING IN EMERGENCY LEGISLATION
FOR PRODUCTS NEEDED TO RESPOND TO THE COVID-19 EMERGENCY

Read More


19

MAR

PMPRB HAS NOW PUBLISHED SUBMISSIONS RECEIVED AS PART OF ITS DRAFT GUIDELINES
CONSULTATION

Read More


16

MAR

PDCI BUSINESS OPERATIONS: BUSINESS [ALMOST] AS USUAL!

Read More


10

MAR

PMPRB CANCELLATION OF MARCH 18TH POLICY FORUM

Read More


26

FEB

INTRODUCING BETWEEN THE LINES: A CANADIAN PHARMACEUTICAL INDUSTRY PODCAST

Read More


25

FEB

SHARING RESPONSES TO THE PATENTED MEDICINE PRICES REVIEW BOARD (PMPRB) DRAFT
GUIDELINES CONSULTATION

Read More


24

FEB

STATUS SUMMARY OF INNOVATIVE MEDICINE PCPA NEGOTIATIONS AS OF JANUARY 31, 2020

Read More


14

FEB

CADTH RELEASES PHARMACEUTICAL REVIEWS UPDATE – ISSUE 13

Read More


13

FEB

PDCI ANALYSIS ESTIMATES IMPACT OF PMPRB DRAFT GUIDELINES TO BE UP TO $41.8
BILLION

Read More


29

JAN

PDCI’S NEW ASSOCIATE DIRECTOR, HTA AND CLINICAL EVALUATION

Read More


15

JAN

STATUS SUMMARY OF INNOVATIVE MEDICINE PCPA NEGOTIATIONS AS OF DECEMBER 31, 2019

Read More


14

JAN

PMPRB AND “ZERO-DOLLAR” SALES

Read More


13

JAN

CADTH RELEASES PHARMACEUTICAL REVIEWS UPDATE – ISSUE 12

Read More


06

JAN

PMPRB CONSULTATION UPDATE AND PATENTEE WEBINAR

Read More


18

DEC

HAPPY HOLIDAYS FROM PDCI MARKET ACCESS!

Read More


10

DEC

STATUS SUMMARY OF INNOVATIVE MEDICINE PCPA NEGOTIATIONS AS OF NOVEMBER 30, 2019

Read More


27

NOV

CADTH RELEASES PHARMACEUTICAL REVIEWS UPDATE – ISSUE 11

Read More


26

NOV

PDCI MARKET ACCESS: PMPRB REFORMS BRIEFING AND STRATEGY SESSIONS (TORONTO AND
MONTREAL)

Read More


22

NOV

STATUS SUMMARY OF INNOVATIVE MEDICINE PCPA NEGOTIATIONS AS OF OCTOBER 31, 2019

Read More


21

NOV

WHITEPAPER: DEBUNKING PRICE REGULATIONS BASED ON THE PHARMACOECONOMIC VALUE
FACTOR

Read More


01

NOV

CANREVALUE RWE WEBINAR & FEEDBACK OPPORTUNITY

Read More


31

OCT

INFOGRAPHIC: THE TRUTH ABOUT THE FEDERAL DRUG PRICING REFORM

Read More


25

OCT

KEELEY FARRELL JOINS PDCI MARKET ACCESS!

Read More


24

OCT

STATUS SUMMARY OF INNOVATIVE MEDICINE PCPA NEGOTIATIONS AS OF SEPTEMBER 30, 2019

Read More


22

OCT

POSTER: PMPRB PROPOSED AMENDMENTS CASE STUDY

Read More


07

OCT

PDCI RESPONSE TO 2019 CADTH CONSULTATIONS

Read More


12

SEP

PDCI MARKET ACCESS: PMPRB WORKSHOPS (TORONTO AND MONTREAL)

Read More


03

SEP

WALEED ADEBAYO JOINS PDCI MARKET ACCESS!

Read More


30

AUG

CADTH RELEASES PHARMACEUTICAL REVIEWS UPDATE 10

Read More


28

AUG

INFOGRAPHIC: CHALLENGES AND GAPS IN GENE & CELL THERAPY ASSESSMENT AND
REIMBURSEMENT PATHWAY

Read More


27

AUG

UPCOMING WEBINAR SEPTEMBER 4: 2019 PMPRB REGULATION AMENDMENTS AND IMPLICATIONS

Read More


19

AUG

HDAP 2020 MEETING DATES RELEASED

Read More


12

AUG

STATUS SUMMARY OF INNOVATIVE MEDICINE PCPA NEGOTIATIONS AS OF JULY 31, 2019

Read More


09

AUG

HEALTH CANADA AMENDMENTS TO PMPRB REGULATIONS

Read More


08

AUG

CADTH RELEASES PHARMACEUTICAL REVIEWS UPDATE ISSUE 9

Read More


08

JUL

STATUS SUMMARY OF INNOVATIVE MEDICINE PCPA NEGOTIATIONS AS OF JUNE 30, 2019

Read More


04

JUL

PDCI ANNOUNCES STRATEGIC PARTNERSHIP WITH GOEREE CONSULTING LTD.

Read More


19

JUN

STATUS SUMMARY OF INNOVATIVE MEDICINE PCPA NEGOTIATIONS AS OF MAY 31, 2019

Read More


18

JUN

PMPRB ANNOUNCES NEW BOARD VICE-CHAIRPERSON

Read More


17

JUN

INTEGRATION OF CDIAC INTO CADTH’S PCODR PROCESS

Read More


14

JUN

FORTHCOMING REVISED PMPRB GUIDELINES

Read More


12

JUN

FINAL REPORT FROM THE ADVISORY COUNCIL ON THE IMPLEMENTATION OF NATIONAL
PHARMACARE

Read More


04

JUN

MANAGING DRUG COSTS BY REGULATING PRICES…BALANCING BUDGET AND ACCESS RISKS IN
THE SEARCH FOR SUSTAINABILITY

Read More


24

MAY

CADTH RELEASES PHARMACEUTICAL REVIEW UPDATE 8

Read More


15

MAY

STATUS SUMMARY OF INNOVATIVE MEDICINE PCPA NEGOTIATIONS AS OF APRIL 30, 2019

Read More


02

MAY

JULIA SHEN JOINS PDCI MARKET ACCESS!

Read More


01

APR

HELENA KOA JOINS PDCI MARKET ACCESS!

Read More


22

MAR

PDCI’S NEW ASSOCIATE DIRECTOR, HTA & HEALTH ECONOMICS

Read More


20

MAR

KIMBERLY ROBINSON JOINS PDCI MARKET ACCESS!

Read More


19

MAR

FEDERAL BUDGET 2019 SUPPORTING THE CREATION OF A CANADIAN DRUG AGENCY

Read More


14

MAR

STATUS SUMMARY OF INNOVATIVE MEDICINE PCPA NEGOTIATIONS AS OF FEBRUARY 28, 2019

Read More


05

MAR

HEALTH CANADA AND CADTH LAUNCH NEW INITIATIVE TO PROVIDE EARLY PARALLEL
SCIENTIFIC ADVICE

Read More


25

FEB

PDCI RESEARCH IDENTIFIES OPPORTUNITIES FOR REIMBURSEMENT OF NICOTINE REPLACEMENT
THERAPIES UNDER EMPLOYER HEALTH PLANS

Read More


22

FEB

CADTH PHARMACEUTICAL REVIEWS UPDATE – ISSUE 5

Read More


15

FEB

STATUS SUMMARY OF INNOVATIVE MEDICINE PCPA NEGOTIATIONS AS OF JANUARY 31, 2019

Read More


11

FEB

EXPENSIVE DRUGS FOR RARE DISEASES – PROVINCIAL WORKING GROUP CONSULTATION

Read More


07

FEB

CADTH LAUNCHES NEW PARALLEL SCIENTIFIC ADVICE PROGRAM

Read More


04

FEB

OBSERVATIONS ON NATIONAL PHARMACARE FROM JOHN-PAUL DOWSON

Read More


17

JAN

STATUS SUMMARY OF NEGOTIATIONS ON BRAND NAME DRUGS AS OF DECEMBER 31, 2018

Read More


08

JAN

ALL 2019 HDAP MEETING DATES RELEASED

Read More


20

DEC

CADTH RELEASES PHARMACEUTICAL REVIEW UPDATE ISSUE 4

Read More


19

DEC

HOLIDAY GREETINGS

Read More


12

NOV

NEW INESSS WEBSITE LAUNCHED

Read More


02

NOV

PMPRB OCTOBER 2018 NEWSLETTER RELEASED

Read More


23

OCT

REGISTER FOR THE MARKET ACCESS SUMMIT AND SAVE 20% WITH PDCI

Read More


23

OCT

WELCOME PDCI NEW HIRES!

Read More


01

OCT

REMINDER: PDCI IS SHARING RESPONSES TO THE NATIONAL PHARMACARE CONSULTATION

Read More


28

AUG

PDCI SHARING RESPONSES TO PHARMACARE CONSULTATION

Read More


27

AUG

PMPRB 2017 ANNUAL REPORT RELEASED

Read More


30

JUL

ANNOUNCEMENT – COURTNEY ABUNASSAR

Read More


03

JUL

CADTH PUBLISHES NEW CDR GUIDELINES & THERAPEUTIC REVIEW PROCESS, PROVIDING
FRAMEWORK TO REVISE CDEC RECOMMENDATIONS

Read More


28

JUN

HEALTH CANADA, CADTH & INESS COLLABORATE ON ALIGNED DRUG REVIEW PROCESSES

Read More


14

JUN

PCPA RELEASES ITS BRAND PROCESS GUIDELINES

Read More


31

MAY

CADTH PUBLISHES CDR UPDATE – ISSUE 136

Read More


22

MAY

JOIN PDCI AT THE 4TH ANNUAL CANADIAN INSTITUTE PHARMA SYMPOSIUM & SAVE 10% OFF
REGISTRATION

Read More


11

MAY

PMPRB’S MAY 2018 NEWSLETTER UPDATES GUIDELINE REFORM TIMELINES

Read More


04

MAY

THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE (PCPA): NEGOTIATIONS STATUS UPDATE

Read More


30

APR

INESSS UPDATES SUBMISSION GUIDE, CHECKLISTS AND TEMPLATE FORMS

Read More


19

APR

STANDING COMMITTEE ON HEALTH PUBLISHES REPORT & RECOMMENDATIONS ON NATIONAL
PHARMACARE

Read More


12

APR

NEW PCODR PATIENT INPUT TIP SHEET AVAILABLE

Read More


12

APR

SASKATCHEWAN BUDGET 2018-19: PROVINCE TO PROVIDE HIV MEDICATIONS AT NO COST

Read More


12

APR

THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE (PCPA): NEGOTIATIONS STATUS UPDATE

Read More


05

APR

INESSS RELEASES ADDITIONAL INFORMATION ON THE EVALUATION PROCESS

Read More


29

MAR

REMINDER: NEW PRICES FOR GENERICS UNDER PCPA/CGPA AGREEMENT BECOME EFFECTIVE
APRIL 1ST, 2018

Read More


21

MAR

CADTH INVITES STAKEHOLDER FEEDBACK ON PROPOSED REVISIONS TO THE PCODR CLINICIAN
ENGAGEMENT PROCESS

Read More


09

MAR

CADTH COMMON DRUG REVIEW RELEASES NEW UPDATE

Read More


08

MAR

PMPRB MARCH 2018 NEWSLETTER RELEASED

Read More


27

FEB

FEDERAL FINANCE MINISTER UNVEILS ADVISORY COUNCIL ON THE IMPLEMENTATION OF
NATIONAL PHARMACARE IN BUDGET 2018

Read More


23

FEB

QUÉBEC GAZETTE ANNOUNCES DRAFT REGULATIONS FOR IMPLEMENTATION OF FEES FOR INESSS
SUBMISSIONS

Read More


14

FEB

CADTH COMMON DRUG REVIEW RELEASES NEW UPDATE

Read More


08

FEB

THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE (PCPA): NEGOTIATIONS STATUS UPDATE

Read More


07

FEB

PMPRB FORM 3 (R&D) DUE DATE REMINDER

Read More


01

FEB

NEW PDCI REPORT FINDS HEALTH CANADA SIGNIFICANTLY OVERSTATES BENEFITS &
UNDERESTIMATES NEGATIVE IMPACT OF ITS PROPOSED REGULATORY AMENDMENTS

Read More


30

JAN

INESSS RELEASES ADDITIONAL INFORMATION – REQUESTS FOR CHANGES OF AN
ADMINISTRATIVE NATURE

Read More


29

JAN

PROPOSED AMENDMENTS TO THE PATENTED MEDICINES REGULATIONS: A CRITICAL APPRAISAL
OF THE COST-BENEFIT ANALYSIS

Read More


22

JAN

PMPRB MYTH BUSTING (I): THE IMAGINARY LINK BETWEEN CANADIAN PRICE CONTROLS AND
R&D EXPENDITURES

Read More


15

JAN

THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE (PCPA): NEGOTIATIONS STATUS UPDATE

Read More


21

DEC

CADTH COMMON DRUG REVIEW RELEASES NEW UPDATE

Read More


20

DEC

HAPPY HOLIDAYS FROM PDCI MARKET ACCESS

Read More


14

DEC

TODAY AT 1 PM: GOVERNMENT OF CANADA OFFICIALS TO SPEAK ON PROPOSED REGULATORY
AMENDMENTS

Read More


11

DEC

PMPRB RELEASES GUIDELINES SCOPING PAPER WITH OVERVIEW OF POTENTIAL NEW FRAMEWORK

Read More


07

DEC

THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE (PCPA): NEGOTIATIONS STATUS UPDATE

Read More


05

DEC

HEALTH CANADA RELEASES PROPOSED PMPRB PRICE REGULATIONS – THE CHARGE OF THE
PRICE BRIGADE

Read More


04

DEC

PDCI WEBINAR: PROPOSED AMENDMENTS TO PATENTED MEDICINES REGULATIONS – WHAT
PATENTEES NEED TO KNOW

Read More


04

DEC

MANITOBA HEALTH AMENDS SUBMISSION REQUIREMENTS

Read More


01

DEC

PROPOSED AMENDMENTS TO PATENTED MEDICINES REGULATIONS ANNOUNCED

Read More


29

NOV

INESSS RELEASES ADDITIONAL INFORMATION ON THE CONTINUOUS EVALUATION PROCESS

Read More


29

NOV

PDCI’S TOP 5 TIPS: BLOCK 5

Read More


28

NOV

CADTH COMMON DRUG REVIEW RELEASES NEW UPDATE

Read More


27

NOV

2017 QUÉBEC CITY HEALTHCARE INDUSTRY FORUM

Read More


16

NOV

INESSS RELEASES ADDITIONAL INFORMATION ON THE CONTINUOUS EVALUATION PROCESS

Read More


16

NOV

CADTH COMMON DRUG REVIEW RELEASES NEW UPDATE

Read More


08

NOV

THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE (PCPA): NEGOTIATIONS STATUS UPDATE

Read More


08

NOV

INESSS RELEASES ADDITIONAL INFORMATION ON THE CONTINUOUS EVALUATION PROCESS

Read More


08

NOV

NATIONAL PHARMACARE: NO NEED FOR “REPEAL & REPLACE” CANADIAN EDITION

Read More


03

NOV

INESSS RELEASES LIST OF DRUG PRODUCTS CURRENTLY BEING REVIEWED UNDER THE
CONTINUOUS EVALUATION PROCESS

Read More


01

NOV

PMPRB 2016 ANNUAL REPORT RELEASED

Read More


31

OCT

PDCI IS EXCITED TO ANNOUNCE ANOTHER GREAT ADDITION TO THE PDCI TEAM: JOHN-PAUL
DOWSON, DIRECTOR, REIMBURSEMENT STRATEGY

Read More


30

OCT

PDCI WELCOMES JENNIFER HAIG AS MANAGER, HTA AND HEALTH ECONOMICS

Read More


18

OCT

RAMQ: OCTOBER 2017 UPDATE FOR THE LIST OF MEDICATIONS

Read More


17

OCT

INESSS RELEASES ADDITIONAL INFORMATION ON THE CONTINUOUS EVALUATION OF DRUG
PRODUCTS – MANDATORY NOTIFICATION

Read More


12

OCT

CADTH COMMON DRUG REVIEW RELEASES NEW UPDATE

Read More


11

OCT

THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE (PCPA): NEGOTIATIONS STATUS UPDATE

Read More


29

SEP

PMPRB HEARING PANEL DECISION RELEASED: SOLIRIS

Read More


29

SEP

INESSS RELEASES ADDITIONAL INFORMATION ON THE CONTINUOUS EVALUATION OF DRUG
PRODUCTS

Read More


29

SEP

CADTH COMMON DRUG REVIEW RELEASES NEW UPDATE

Read More


12

SEP

REVEALING PAYMENTS TO PHYSICIANS: “HEALTH LEADERS” GOING DOWN THE WRONG ROAD
WITH THE PMPRB.

Read More


12

SEP

CADTH COMMON DRUG REVIEW RELEASES NEW UPDATE

Read More


11

SEP

THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE (PCPA): NEGOTIATIONS STATUS UPDATE

Read More


08

SEP

NOTICE TO MANUFACTURERS – MEDICATIONS UNDER REVIEW FOR FEBRUARY 2018 LIST UPDATE

Read More


23

AUG

NOW LIVE: PDCI’S INFORMATION SHARING WEBPAGE: RESPONSES TO HEALTH CANADA’S
PATENTED MEDICINES REGULATIONS CONSULTATION

Read More


22

AUG

SHARING RESPONSES ON PROPOSED AMENDMENTS TO THE PATENTED MEDICINES REGULATIONS

Read More


21

AUG

NOTICE TO MANUFACTURERS – CLARIFICATION OF LIST UPDATE SCHEDULE IN 2018

Read More


14

AUG

CADTH COMMON DRUG REVIEW RELEASES CDR UPDATE – ISSUE 126

Read More


09

AUG

THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE (PCPA): NEGOTIATIONS STATUS UPDATE

Read More


28

JUL

RELEASE OF PMPRB ANNUAL REPORT DELAYED (AGAIN) – SO MUCH FOR TRANSPARENCY…

Read More


25

JUL

2018 HDAP MEETING SCHEDULE

Read More


14

JUL

CADTH COMMON DRUG REVIEW RELEASES NEW UPDATE

Read More


13

JUL

ONTARIO DRUG BENEFIT ACT TO CREATE AND IMPLEMENT OHIP+: CHILDREN AND YOUTH
PHARMACARE PROGRAM

Read More


11

JUL

THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE (PCPA): NEGOTIATIONS STATUS UPDATE

Read More


15

JUN

THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE (PCPA): NEGOTIATIONS STATUS UPDATE

Read More


13

JUN

UPDATE: QUÉBEC – INESSS SUBMISSION DEADLINE FOR AUGUST 2017

Read More


09

JUN

CADTH COMMON DRUG REVIEW RELEASES NEW UPDATE

Read More


09

JUN

PDCI MARKET ACCESS WEBINAR: INFORMATION SESSION FOR INDUSTRY ON NEW INESSS
SUBMISSION GUIDELINES AND IMPLEMENTATION OF PRE-NOC REVIEW PROCEDURE

Read More


06

JUN

NEW: INESSS RELEASES NEW SUBMISSION GUIDELINES – IMPLEMENTATION OF PRE-NOC
REVIEW PROCEDURE

Read More


30

MAY

THE PMPRB RELEASES ITS MAY 2017 NEWSLETTER

Read More


25

MAY

PDCI MARKET ACCESS WEBINAR: INFORMATION SESSION FOR INDUSTRY ON PROPOSED
AMENDMENTS TO PATENTED MEDICINES REGULATIONS

Read More


16

MAY

PATENTED MEDICINES REGULATIONS CONSULTATION OPEN

Read More


16

MAY

THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE (PCPA): NEGOTIATIONS STATUS UPDATE

Read More


03

MAY

PDCI WELCOMES STRATEGIC PARTNER JOHN-PAUL DOWSON!

Read More


02

MAY

JOIN PDCI AT 3RD ANNUAL CANADIAN INSTITUTE PHARMA SYMPOSIUM

Read More


19

APR

NEW NPDUIS REPORT RELEASED – PMPRB MEDS ENTRY WATCH

Read More


19

APR

NEW INESSS QUESTIONNAIRES RELEASED FOR MEDICINES UNDER REVIEW

Read More


13

APR

THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE (PCPA): NEGOTIATIONS STATUS UPDATE

Read More


28

MAR

CADTH’S UPDATED GUIDELINES FOR THE ECONOMIC EVALUATION OF HEALTH TECHNOLOGIES –
4TH EDITION NOW AVAILABLE

Read More


17

MAR

NEW CADTH PROCESSES AND MARCH NEWSLETTER

Read More


16

MAR

THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE (PCPA): NEGOTIATIONS STATUS UPDATE

Read More


15

MAR

CADTH SPECIAL EVENT: NEW GUIDELINES FOR THE ECONOMIC EVALUATION OF HEALTH
TECHNOLOGIES: CANADA

Read More


15

MAR

INESSS MANUFACTURER APPOINTMENTS

Read More


17

FEB

PMPRB FORM 3 REMINDER

Read More


06

FEB

KAITLYN PROULX APPOINTED MANAGING DIRECTOR

Read More


06

DEC

HEALTH CANADA RELEASES GUIDANCE DOCUMENT FOR BIOSIMILAR BIOLOGIC DRUG
SUBMISSIONS

Read More


02

DEC

PMPRB’S PHASE 1 OF RETHINKING THE GUIDELINES PUBLIC COMMENTS NOW AVAILABLE

Read More


01

DEC

ALBERTA CHANGES SPECIAL AUTHORIZATION CRITERIA FOR COVERAGE OF INFLECTRA™
(INFLIXIMAB)

Read More


28

NOV

ONTARIO PUBLIC DRUG PROGRAMS FUNDS NEW INDICATIONS FOR INFLECTRA™ (INFLIXIMAB)

Read More


23

NOV

PMPRB VICE CHAIR RE-APPOINTED

Read More


09

NOV

PRIVATE PAYER PRODUCT LISTING AGREEMENTS IN CANADA – SECOND JOINT INDUSTRY/PAYER
SURVEY RESULTS – NOW AVAILABLE

Read More


31

OCT

REGISTRATION IS OPEN FOR CAHR’S 6TH ANNUAL NATIONAL DAY

Read More


20

OCT

INESSS MANUFACTURER APPOINTMENTS

Read More


13

OCT

THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE (PCPA): NEGOTIATIONS STATUS UPDATE

Read More


11

OCT

APPLICATION OF GENERIC SUBSTITUTION TO THE EXCEPTIONAL ACCESS PROGRAM (EAP)

Read More


04

OCT

ADDENDUM #1 TO ONTARIO GUIDELINES FOR DRUG SUBMISSION AND EVALUATION TO THE
ONTARIO PUBLIC DRUG PROGRAMS

Read More


28

SEP

ALBERTA RELEASES NEW AMENDMENTS TO PRICE POLICY

Read More


26

SEP

ONTARIO RELEASES NEW AMENDMENTS TO REGULATION 201/96 UNDER THE ODBA REGULATION
AND REGULATION 935 UNDER THE DIDFA REGULATION

Read More


20

SEP

ONTARIO RELEASES UPDATED GUIDELINES FOR DRUG SUBMISSION AND EVALUATION 2016

Read More


13

SEP

FEEDBACK ON PROPOSED REVISIONS TO PATIENT INPUT TEMPLATE FOR CDR AND PCODR

Read More


08

SEP

THE PCPA: NEGOTIATIONS STATUS UPDATE

Read More


26

AUG

REGISTRATION IS UNDERWAY FOR THE CAHR MARKET ACCESS 201 COURSE

Read More


26

AUG

PDCI MARKET ACCESS WEBINAR ‒ POSSIBLE 2ND SESSION SEPTEMBER 8, 2016 (DATE
TENTATIVE)

Read More


19

AUG

PMPRB 2015 ANNUAL REPORT RELEASED

Read More


17

AUG

THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE (PCPA): NEGOTIATIONS STATUS UPDATE

Read More


12

AUG

PDCI MARKET ACCESS WEBINAR ‒ INFORMATION SESSION ON THE PMPRB GUIDELINES
MODERNIZATION DISCUSSION PAPER

Read More


10

AUG

PDCI MARKET ACCESS WEBINAR ‒ INFORMATION SESSION ON THE PMPRB GUIDELINES
MODERNIZATION DISCUSSION PAPER

Read More


05

AUG

THE PMPRB RELEASES ITS JULY 2016 NEWSLETTER

Read More


29

JUL

SAVE THE DATE

Read More


21

JUL

PMPRB 2015 ANNUAL REPORT

Read More


12

JUL

THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE (PCPA): NEGOTIATIONS STATUS UPDATE

Read More


04

JUL

PMPRB GUIDELINE MODERNIZATION – PDCI TO HOLD INDUSTRY INFORMATION SESSIONS IN
AUGUST / SEPTEMBER

Read More


27

JUN

PMPRB – DISCUSSION PAPER RELEASED – BOARD DOWN TO 2 BOARD MEMBERS AS OF JUNE 27
– 2015 ANNUAL REPORT BOARD DELAYED

Read More


20

JUN

PDCI RELEASES NEW REPORT ON PCPA BEST PRACTICES, TRENDS AND OUTLOOK

Read More


03

JUN

BC PHARMACARE UPCOMING MODERNIZATION OF THE REFERENCE DRUG PROGRAM

Read More


01

JUN

RAMQ: JUNE 2016 UPDATE FOR THE LIST OF MEDICATIONS

Read More


26

MAY

CADTH CDR AND PCODR ENGAGEMENT WITH THE PCPA

Read More


25

MAY

NOVA SCOTIA PHARMACARE FUNDS INFLECTRA™ (INFLIXIMAB)

Read More


18

MAY

THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE (PCPA): NEGOTIATIONS STATUS UPDATE

Read More


17

MAY

CADTH RELEASES RECOMMENDATIONS REPORT FOR ANTI-VASCULAR ENDOTHELIAL GROWTH
FACTOR DRUGS FOR RETINAL CONDITIONS

Read More


03

MAY

THE PMPRB RELEASES ITS APRIL 2016 NEWSLETTER

Read More


03

MAY

SEEKING PARTICIPATION IN THE 2016 PRIVATE PAYER PLA SURVEY

Read More


22

APR

NEW DRUG REVIEW PROCESS DEVELOPED BY INESSS FOR STABLE BLOOD PRODUCTS

Read More


19

APR

THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE (PCPA) RELEASES ITS APRIL 1ST, 2016
UPDATE

Read More


11

APR

THE PCPA RELEASES FIRST PRINCIPLES FOR SUBSEQUENT ENTRY BIOLOGICS

Read More


30

MAR

NEW IMPLEMENTATION DATES FOR REVISIONS TO THE PROCEDURE FOR VOLUNTARY WITHDRAWAL
AND PROVIDING CDR REVIEW TEAM’S RESPONSES

Read More


30

MAR

MINIMUM PERIOD OF 120 CALENDAR DAYS FOR ADVANCE NOTIFICATION OF ANTICIPATED
SUBMISSIONS AND RESUBMISSIONS FOR CADTH’S CDR AND PCODR PROGRAMS

Read More


24

MAR

THE PMPRB TO IMPLEMENT NEXT STEPS REGARDING THE COMPENDIUM OF POLICIES,
GUIDELINES AND PROCEDURES IN JUNE 2016

Read More


24

MAR

ONTARIO’S CED WILL NO LONGER ROUTINELY EVALUATE CDR- OR PCODR-REVIEWED DRUG
PRODUCTS

Read More


15

MAR

ONTARIO PUBLIC DRUG PROGRAMS FUNDS INFLECTRA™ (INFLIXIMAB)

Read More


15

MAR

CADTH CALL FOR PATIENT INPUT FOR INFLECTRA™ (SUBSEQUENT ENTRY BIOLOGIC)

Read More


10

MAR

CADTH CALL FOR PATIENT INPUT FOR ETANERCEPT SEB

Read More


10

MAR

PROPOSAL TO AMEND ONTARIO REGULATION 201/96 UNDER THE ONTARIO DRUG BENEFIT ACT
TO UPDATE COST-SHARING ARRANGEMENTS FOR NON-LOW INCOME SENIORS UNDER THE ONTARIO
DRUG BENEFIT PROGRAM

Read More


29

FEB

PDCI PHARMACARE COSTING STUDY REPORT 2016 – FINAL

Read More


26

FEB

UPDATE ON PROCEDURES FOR THE CADTH COMMON DRUG REVIEW AND PAN-CANADIAN ONCOLOGY
DRUG REVIEW: MANDATORY DISCLOSURE OF A SUBMITTED DRUG PRICE

Read More


23

FEB

PCPA FEBRUARY UPDATE – FEDERAL DRUG PLANS OFFICIALLY JOIN THE PCPA AND THE FULL
OFFICE TEAM IS NOW IN PLACE

Read More


17

FEB

ONTARIO LISTING OF INFLECTRA

Read More


17

FEB

ALEXION PCPA NEGOTIATION

Read More


12

FEB

ALBERTA HEALTH RELEASES PRICE CONFIRMATION TENTATIVE DATES

Read More


12

FEB

PMPRB NEW REPORT: GENERICS360 – GENERIC DRUGS IN CANADA, 2014

Read More


12

FEB

MODIFICATIONS TO THE PROCEDURE FOR FILING A DRUG SUBMISSION APPLICATION FOR
GENERIC DRUGS WITH INESSS

Read More


02

FEB

NEW PILOT INITIATIVE: INCREASING OPPORTUNITIES FOR CLINICAL INPUT AND FEEDBACK
IN CADTH PAN-CANADIAN ONCOLOGY DRUG REVIEW PROCESS

Read More


20

JAN

C-MAP™ CANADIAN DRUG BENEFIT PLANS REFERENCE GUIDE 2016 EDITION NOW AVAILABLE!

Read More


18

JAN

PHARMACARE COSTING IN CANADA: PRELIMINARY REPORT

Read More


21

DEC

PMPRB RELEASES STRATEGIC PLAN 2015-2018

Read More


14

DEC

PATENTED MEDICINE PRICES REVIEW BOARD RELEASES 2014 ANNUAL REPORT

Read More


14

DEC

UPDATES TO THE GUIDELINES FOR THE ECONOMIC EVALUATION OF HEALTH TECHNOLOGIES:
CANADA

Read More


14

DEC

QUÉBEC MOVES TO INTRODUCE A TENDERING SYSTEM FOR DRUGS

Read More


04

DEC

ONTARIO RELEASES SUMMARY OF MINISTER’S ROUNDTABLE ON PHARMACARE

Read More


25

NOV

PDCI STRATEGIC ADVICE SERVICES FOR PRODUCT LISTING AGREEMENTS

Read More


13

NOV

PMPRB WINS AT FEDERAL COURT OF APPEAL – MAINTAINS JURISDICTION OVER PATENTED
GENERIC PRODUCTS

Read More


03

NOV

PRESENTATION AND POLL RESULTS FROM PDCI MARKET ACCESS PRODUCT LISTING AGREEMENT
(PLA) WEBINAR IS NOW AVAILABLE

Read More


26

OCT

CADTH: EXTENDING DEADLINE ON CONSULTATION ON PROCEDURES FOR THE CADTH COMMON
DRUG REVIEW

Read More


26

OCT

CAHR NATIONAL DAY: NATIONAL APPROACHES TO PHARMA POLICY: INTERNATIONAL &
CANADIAN PERSPECTIVES

Read More


20

OCT

PDCI MARKET ACCESS WEBINAR ‒ MARKET ACCESS CLIMATE CHANGE: THE EVOLVING IMPACT
OF PRODUCT LISTING AGREEMENTS

Read More


16

OCT

QUÉBEC: INESSS UPCOMING MEETINGS WITH MANUFACTURERS – JUNE 2016 “LISTE DES
MÉDICAMENTS”

Read More


16

OCT

PCPA OCTOBER UPDATE – QUÉBEC OFFICIALLY JOINS THE PCPA & THE PCPA OFFICE IS NOW
OPERATIONAL

Read More


06

OCT

EXPANDING THE CADTH DRUG REVIEW PROCESS TO RECEIVE PATIENT INPUT SUBMISSIONS
FROM INDIVIDUAL PATIENTS AND CAREGIVERS

Read More


30

SEP

MANULIFE DRUGWATCH™ & PRIVATE PAYER PRODUCT LISTING AGREEMENT (PLA) SERIES

Read More


17

SEP

PRIVATE PAYER PRODUCT LISTING AGREEMENT (PLA) SERIES

Read More


09

SEP

PRIVATE PAYER PRODUCT LISTING AGREEMENT (PLA) SERIES

Read More


03

SEP

PRIVATE PAYER PRODUCT LISTING AGREEMENT (PLA) SERIES

Read More


31

JUL

THE PMPRB HAS RELEASED ITS JULY 2015 NEWSLETTER

Read More


27

JUL

ONTARIO PUBLIC DRUG PROGRAMS DIVISION

Read More


20

JUL

EXCEPTIONAL RESPONSE TO PDCI/H3 PRIVATE PAYER PLA SURVEY

Read More


24

JUN

PRIVATE PAYER PLA SURVEY

Read More


23

JUN

AUSTRALIA’S PHARMACEUTICAL BENEFITS ADVISORY COMMITTEE RECOMMENDS SUBSTITUTION
OF BIOSIMILARS

Read More


19

JUN

QUEBEC: INESSS UPCOMING MEETINGS WITH MANUFACTURERS – FEBRUARY 2016 “LISTE DES
MÉDICAMENTS”

Read More


12

JUN

QUÉBEC – INESSS SUBMISSION DEADLINES: 2015-2016

Read More


08

JUN

PDCI INTERNATIONAL TRENDS SERIES PART 5

Read More


27

MAY

BC: UPDATES TO BC DRUG REVIEW PROCESS AND SUBMISSION REQUIREMENTS

Read More


27

MAY

ON: AMENDMENTS TO ONTARIO REGULATION 201/96

Read More


26

MAY

PDCI INTERNATIONAL TRENDS SERIES PART 4

Read More


25

MAY

CANADIAN ORGANIZATION FOR RARE DISORDERS (CORD) TO RELEASE FIRST EVER RARE
DISEASE STRATEGY

Read More


19

MAY

PDCI INTERNATIONAL TRENDS SERIES PART 3

Read More


14

MAY

PDCI INTERNATIONAL TRENDS SERIES PART 2

Read More


04

MAY

PDCI INTERNATIONAL TRENDS SERIES

Read More


10

APR

WIB-GREATER MONTREAL AND THE TECHNOPARC MONTRÉAL PRESENT A CONFERENCE ON DRUG
REIMBURSEMENT IN QUEBEC

Read More


10

APR

UPDATES TO THE MANUFACTURER SUBMISSION REQUIREMENTS IN THE ALBERTA DRUG BENEFIT
LIST (ADBL)

Read More


07

APR

CADTH: GUIDELINES FOR MANUFACTURERS ON PCODR APPLICATION FEES IMPLEMENTED

Read More


30

MAR

RARE DISEASES CAMPAIGN

Read More


25

MAR

THE PAN-CANADIAN ONCOLOGY DRUG REVIEW (PCODR) IS MOVING

Read More


25

MAR

PDCI CANADIAN DRUG CLAIMS DATABASE FREE TRIAL NOW AVAILABLE!

Read More


12

MAR

CADTH REVISED CATEGORY 1 REQUIREMENTS FOR TAILORED CDR REVIEWS

Read More


05

MAR

GUIDELINES FOR MANUFACTURERS ON APPLICATION FEES FOR PCODR

Read More


02

MAR

‘SUCCESSFUL CDR, PCODR & INESSS SUBMISSIONS’ WORKSHOP CANCELLED

Read More


23

FEB

PAN-CANADIAN GENERICS – CENTRALIZED PRICE CONFIRMATION PROCESS

Read More


09

FEB

INTERVIEW WITH PCPA ON THE GUIDELINES FOR NEGOTIATIONS

Read More


04

FEB

CADTH UPDATE FOR PATIENT GROUPS — JANUARY 2015

Read More


04

FEB

PMPRB UPDATE – JANUARY 2015 NEWSLETTER

Read More


14

JAN

DRUG PRODUCTS UNDERGOING EVALUATION FOR THE JUNE 2015 “LISTE DES MÉDICAMENTS”

Read More


05

JAN

CDEC FINAL RECOMMENDATION FOR INFLECTRA POSTED

Read More


22

DEC

HAPPY HOLIDAYS FROM PDCI!

Read More


14

NOV

PMPRB HAS RELEASED ITS OCTOBER 2014 NEWSLETTER

Read More


06

NOV

PROPOSED REGULATION AMENDMENTS TO ESTABLISH A PRICING FRAMEWORK FOR GENERIC
PRODUCTS

Read More


03

NOV

PDCI CAREER OPPORTUNITY

Read More


03

NOV

VOLUNTARY COMPLIANCE UNDERTAKING OF VALEANT CANADA LP TO PMPRB

Read More


24

OCT

PATENTED MEDICINES PRICES REVIEW BOARD (PMPRB) OUTREACH SESSIONS

Read More


22

OCT

MEETINGS WITH MANUFACTURERS FOR THE JUNE 2015 “LISTE DES MÉDICAMENTS”

Read More


16

OCT

IBM “PAN CANADIAN DRUGS NEGOTIATION REPORT” NOW AVAILABLE

Read More


08

OCT

WELCOME ANITA!

Read More


07

OCT

PDCI PAN-CANADIAN PHARMACEUTICAL ALLIANCE (PCPA) BENCHMARKING SURVEY REPORT –
NOW AVAILABLE!

Read More


03

OCT

CADTH UPDATES FOR PATIENT GROUPS

Read More


02

OCT

PMPRB: THE PMPRB LAUNCHES ITS NEW WEBSITE

Read More


02

OCT

QUEBEC: OCTOBER UPDATE FOR THE “LISTE DES MÉDICAMENTS”

Read More


18

SEP

PMPRB: NEW ENHANCED PMPRB WEBSITE COMING SOON

Read More


16

SEP

PMPRB: 2013 ANNUAL REPORT RELEASED

Read More


16

SEP

CADTH: REVISED GUIDELINES FOR MANUFACTURERS ON APPLICATION FEES

Read More


18

AUG

15TH ANNIVERSARY EDITION OF THE C-MAP™ CANADIAN DRUG BENEFIT PLANS REFERENCE
GUIDE

Read More


06

AUG

CADTH DIRECT-ACTING ANTIVIRALS FOR CHRONIC HEPATITIS C GENOTYPE 1

Read More


05

AUG

PMPRB HAS RELEASED ITS JULY 2014 NEWSLETTER

Read More


31

JUL

CADTH: FEEDBACK REQUESTED ON INDUSTRY APPLICATION FEE GUIDELINES

Read More


30

JUL

CADTH: CDR UPDATE – ISSUE 106

Read More


29

JUL

NEW BRUNSWICK: RARE DISEASES DRUG PLAN ESTABLISHED

Read More


24

JUL

PCODR: SUMMARY REPORT FROM STAKEHOLDER CONSULTATIONS ON TRANSFER OF PCODR TO
CADTH

Read More


09

JUL

PMPRB 2013 ANNUAL REPORT DELAYED

Read More


08

JUL

CADTH: CDR UPDATE – ISSUE 105 – PATIENT INPUT

Read More


08

JUL

QUEBEC: INESSS TO HAVE MEETINGS WITH MANUFACTURERS FOR FEBRUARY 2015 LISTE DES
MÉDICAMENTS UPDATE

Read More


27

JUN

PMPRB FEDERAL COURT DECISION APPEALED

Read More


16

JUN

QUEBEC: SUBMISSION DEADLINES PUBLISHED

Read More


29

MAY

PMPRB JURISDICTION DOES NOT EXTEND TO GENERICS (FEDERAL COURT DECISIONS)

Read More


27

MAY

UPDATE ON PCODR PROCEDURES AND GUIDELINES CONSULTATION

Read More


26

MAY

CADTH: COMMON DRUG REVIEW (CDR) UPDATE – ISSUE 104

Read More


25

MAY

INVITATION TO ATTEND PMPRB OUTREACH SESSIONS

Read More


24

MAY

COMMON DRUG REVIEW (CDR) INTRODUCES NEW APPLICATION FEE FOR SUBMISSIONS

Read More


23

MAY

THE PMPRB RELEASES THE APRIL 2014 ISSUE OF ITS NEWSLETTER

Read More


23

MAY

QUÉBEC: UPDATE TO THE LISTE DE MÉDICAMENTS

Read More


22

MAY

CADTH: CDEC TO REVIEW DRUGS FOR RARE DISEASES VIA “ENHANCED” CDR PROCESS

Read More


20

MAR

SUBSEQUENT ENTRY BIOLOGICS IN CANADA: STAKEHOLDERS DISCUSS THE REGULATORY,
PRICING AND REIMBURSEMENT LANDSCAPE.

Read More


20

MAR

EXECUTIVE BRIEFING PHARMACEUTICAL PRICING AND REIMBURSEMENT IN CANADA 2012
EDITION

Read More


20

MAR

NATIONAL PHARMACARE COST IMPACT STUDY

Read More


20

MAR

GENERIC DRUG PRICES: A CANADA US COMPARISON

Read More


20

MAR

CANADA’S BALANCE OF TRADE IN PHARMACEUTICALS

Read More


20

MAR

PARLIAMENTARY REVIEW OF BILL C-91: BACKGROUND STUDY ON DRUG COSTS AND BENEFITS

Read More


18

FEB

ACTUAL CPI IN 2013 AND IMPLICATIONS FOR PMPRB PRICE COMPLIANCE

Read More


18

FEB

SECOND PHASE OF GENERIC PRICING POLICY IMPLEMENTED YESTERDAY

Read More


18

FEB

PREMIER ANNOUNCES NEW CATASTROPHIC DRUG COVERAGE PROGRAM

Read More


18

FEB

GENERIC DRUG PRICES DROP TO 35 PER CENT OF BRAND

Read More


18

FEB

PROVINCIAL GOVERNMENT INVESTS $2.4 MILLION IN HEALTH RESEARCH

Read More


18

FEB

INESSS TO HAVE MEETINGS WITH MANUFACTURERS FOR JUNE 2014 LISTE DES MÉDICAMENTS
UPDATE

Read More


18

FEB

UPDATE TO THE LISTE DE MÉDICAMENTS

Read More


18

FEB

HIGH-INCOME SENIORS TO PAY MORE FOR DRUGS

Read More


18

FEB

PRICE FOR TOP 10 GENERIC DRUGS CUT TO 20% OF BRAND PRICE

Read More


18

FEB

NEW DRUGS ON FORMULARY EXPECTED TO SAVE $10 MILLION/YEAR

Read More


18

FEB

PROVINCE ANNOUNCES IT WILL REIMBURSE 100% OF THE COSTS OF ORAL CANCER DRUGS

Read More


18

FEB

120 NEW DRUGS ADDED TO PHARMACARE LAST MONTH

Read More


18

FEB

SOME SENIORS’ AND CHILDREN’S PRESCRIPTIONS TO COST MORE

Read More


18

FEB

ONLINE PROCESSING TO HELP SASKATCHEWAN-BASED TRAVELLERS RECEIVE SIX-MONTH
SUPPLIES OF DRUGS

Read More


18

FEB

PROVINCE INTRODUCES PHARMACEUTICAL SERVICES ACT

Read More


18

FEB

DRUG MANUFACTURER SUBMISSION DEADLINES FOR LISTING ON THE AHWDBL HAVE BEEN
UPDATED

Read More


18

FEB

18% GENERIC DRUG PRICING POLICY EFFECTIVE MARCH 15, 2013

Read More


18

FEB

CDR UPDATE — ISSUE 98

Read More


18

FEB

ENVIRONMENTAL SCAN ON SUBSEQUENT ENTRY BIOLOGICS RELEASED

Read More


18

FEB

CADTH TO POST PATIENT INPUT SUBMISSIONS AS OF FEBRUARY 1, 2014

Read More


18

FEB

CANADIAN DRUG EXPERT COMMITTEE (CDEC) MEETING SCHEDULE

Read More


18

FEB

EFFECTIVE APRIL 1 2014: PCODR IS TRANSFERRING TO CADTH

Read More


14

FEB

NEW PDCI STUDY!

Read More


14

FEB

EFFECTIVE APRIL 1 2014: PCODR IS TRANSFERRING TO CADTH

Read More


13

FEB

PMPRB

Read More


12

FEB

CADTH

Read More

NEWSLETTER SIGN UP

TargetPharma is PDCI Market Access’ Free E-mail Newsletter

Sign Up

TARGETPHARMA

TargetPharma is a free e-mail newsletter featuring the latest developments
on policy, pricing and reimbursement in the pharmaceutical industry at the
provincial and federal levels. Subscribe to stay informed on relevant activities
within the PMPRB, the pCPA, CADTH (CDR and pCODR), Health Canada, and emerging
issues and trends within Canada.



PDCI Market Access, a division of McKesson Canada Corporation
2300 Meadowvale Blvd.
Mississauga, ON L5N 5S1

Tel: 613-742-8225
Fax: 855-228-1549
E-mail: info@pdci.ca

 * 
 * 




Privacy

If you are a Quebec resident and you have questions or comments about our
efforts to protect your personal privacy, or if you require additional
information about our privacy practices, please contact us at
compliance@mckesson.ca. You may also write to our Privacy Officer at: McKesson
Canada Corporation, Attn: Privacy Officer, 2300, Meadowvale Blvd., Mississauga,
ON, L5N 5P9

© 2024 PDCI Market Access. All rights reserved.
BESbswyBESbswy